Finance

Lists
300049:SHE
Inner Mongolia Furui Medical Scie Co Ltd
CNÂ¥41.99
-0.71%
(-0.30) 1D
Aug 28, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300049...
Open
CNÂ¥42.25
High
CNÂ¥43.47
Low
CNÂ¥41.80
Mkt. cap
11.08B
Avg. vol.
10.54M
Volume
5.36M
Dividend
0.36%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 6, 2026
P/E ratio
67.26
52-wk high
CNÂ¥90.68
52-wk low
CNÂ¥36.50
EPS
CNÂ¥0.62
Shares outstanding
263.99M
No. of employees
946
Open
CNÂ¥42.25
High
CNÂ¥43.47
Low
CNÂ¥41.80
Mkt. cap
11.08B
Avg. vol.
10.54M
Volume
5.36M
Dividend
0.36%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 6, 2026
P/E ratio
67.26
52-wk high
CNÂ¥90.68
52-wk low
CNÂ¥36.50
EPS
CNÂ¥0.62
Shares outstanding
263.99M
No. of employees
946
About Inner Mongolia Furui Medical Scie Co Ltd
CEO-
Employees946
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitefu-rui.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
387.63M
494.34M
360.14M
-
Cost of goods sold
95.98M
127.96M
90.42M
-
Cost of revenue
95.98M
127.96M
90.42M
92.51M
Research and development expenses
31.23M
30.02M
31.52M
33.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
147.34M
193.82M
162.71M
177.75M
Operating expense
181.85M
218.95M
199.63M
-
Total operating expenses
277.83M
346.91M
290.05M
306.24M
Operating income
109.80M
147.44M
70.09M
-
Other non operating income
-36.62M
36.25M
1.41M
-
EBT including unusual items
109.41M
126.75M
73.08M
86.37M
EBT excluding unusual items
105.32M
155.36M
75.20M
-
Income tax expense
25.37M
30.32M
20.96M
23.96M
Effective tax rate
23.19%
23.92%
28.68%
-
Other operating expenses
-170.04K
4.54M
1.65M
-
Net income
59.95M
42.20M
31.79M
-
Net profit margin
15.47%
8.54%
8.83%
-
Earnings per share
-
-
-
-
Interest and investment income
4.38M
4.93M
4.62M
-
Interest expense
-789.00K
-972.81K
-910.86K
-
Net interest expenses
3.59M
3.96M
3.71M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
127.85M
167.13M
89.78M
-
Gain or loss from assets sale
346.49K
-378.46K
-
-100.89K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps